Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma

by Engesæter, Birgit, Engebraaten, Olav, Flørenes, Vivi Ann, Mælandsmo, Gunhild Mari
Published 2012

Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial

by Engebraaten, Olav, Edvardsen, Hege, Løkkevik, Erik, Naume, Bjørn, Kristensen, Vessela, Ottestad, Lars, Natarajan, Vasanti
Published 2012

Differential In Vivo Tumorigenicity of Distinct Subpopulations from a Luminal-Like Breast Cancer Xenograft

by Skrbo, Nirma, Hjortland, Geir-Olav, Kristian, Alexandr, Holm, Ruth, Nord, Silje, Prasmickaite, Lina, Engebraaten, Olav, Mælandsmo, Gunhild M., Sørlie, Therese, Andersen, Kristin
Published 2014

Interplay of choline metabolites and genes in patient-derived breast cancer xenografts

by Grinde, Maria T, Skrbo, Nirma, Moestue, Siver A, Rødland, Einar A, Borgan, Eldrid, Kristian, Alexandr, Sitter, Beathe, Bathen, Tone F, Børresen-Dale, Anne-Lise, Mælandsmo, Gunhild M, Engebraaten, Olav, Sørlie, Therese, Marangoni, Elisabetta, Gribbestad, Ingrid S
Published 2014